StockStory Flags Slower Growth and Margin Pressure at GE HealthCare
The publisher cites modest organic growth, a cautious revenue outlook and declining adjusted margins in its assessment of GE HealthCare.
Key takeaways
- StockStory says GE HealthCare’s organic revenue grew an average of 3% year over year over two years.
- Analysts forecast 4.4% revenue growth over the next 12 months, according to StockStory.
StockStory says GE HealthCare’s recent share-price decline does not make the stock attractive, citing slow growth and pressure on profitability. The publisher noted the shares were at $68 in its article; as of 14:51 UTC on Oct. 13, they traded at $67.95, up 0.31% since the previous close.
The analysis said organic revenue averaged 3% annual growth over the past two years. It also cited sell-side analysts’ forecast for 4.4% revenue growth over the next 12 months, compared with 3.7% annualized growth over the past five years.
StockStory also reported that adjusted operating margin fell 1.7 percentage points over five years and stood at 14.8% for the trailing 12 months. The publisher described the stock’s 12.8 forward P/E as fair but said it had limited confidence in the company.
This article was produced with the help of AI technology. Source: Yahoo Finance
